Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 15:107:55-64.
doi: 10.1016/j.neuroimage.2014.11.058. Epub 2014 Dec 5.

Partial volume correction in quantitative amyloid imaging

Affiliations

Partial volume correction in quantitative amyloid imaging

Yi Su et al. Neuroimage. .

Abstract

Amyloid imaging is a valuable tool for research and diagnosis in dementing disorders. As positron emission tomography (PET) scanners have limited spatial resolution, measured signals are distorted by partial volume effects. Various techniques have been proposed for correcting partial volume effects, but there is no consensus as to whether these techniques are necessary in amyloid imaging, and, if so, how they should be implemented. We evaluated a two-component partial volume correction technique and a regional spread function technique using both simulated and human Pittsburgh compound B (PiB) PET imaging data. Both correction techniques compensated for partial volume effects and yielded improved detection of subtle changes in PiB retention. However, the regional spread function technique was more accurate in application to simulated data. Because PiB retention estimates depend on the correction technique, standardization is necessary to compare results across groups. Partial volume correction has sometimes been avoided because it increases the sensitivity to inaccuracy in image registration and segmentation. However, our results indicate that appropriate PVC may enhance our ability to detect changes in amyloid deposition.

Keywords: Amyloid imaging; PET; Partial volume correction; PiB.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Demonstration of the simulation procedure. A) Example MR data. B) FreeSurfer segmentation of the MR data. A time-activity curve (TAC) was assigned to each ROI. C) Example regional TAC D) Example frame of simulated data after assigning a TAC to each region. E) PET frame smoothed to PET resolution. F) Final simulated dynamic PET frame including noise.
Figure 2
Figure 2
Estimated binding potentials with and without partial volume correction for simulations created with different cortical thickness and amyloid load.
Figure 3
Figure 3
Impact of partial volume effects to binding potential estimation due to longitudinal changes in cortical thickness based on the simulation study.
Figure 4
Figure 4
Trajectories of PiB binding estimated with cross sectional first-degree LOESS curves with and without PVC (top row). And regional time-activity curve with and without PVC for an example subject (bottom row).
Figure 5
Figure 5
Regional binding potentials with and without PVC. Although for individual regions, the PVC corrected BPND were highly correlated with the uncorrected version, the slope of the linear relationship varies from one region to another. On average, the estimaged BPND increased 41±33%, 8±14%, and 31±22% for left precuneus, left putamen and MCBP respectively when RSF PVC is applied; the estimated BPND increased 7±8% for left precuneus, decreased 17±2% for left putamen, and increased 12±5% for MCBP when PVC2C is applied. The percent change is calculated as (BPPVC−BPraw)/(1+BPraw)×100%.

References

    1. Aisen PS. Alzheimer’s disease therapeutic research: the path forward. Alzheimers Res Ther. 2009;1:2. - PMC - PubMed
    1. Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khachaturian ZS, Dubois B, Feldman HH, Petersen RC, Siemers E, Doody RS, Hendrix SB, Grundman M, Schneider LS, Schindler RJ, Salmon E, Potter WZ, Thomas RG, Salmon D, Donohue M, Bednar MM, Touchon J, Vellas B. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011;76:280–286. - PMC - PubMed
    1. Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65:1509–1517. - PMC - PubMed
    1. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804. - PMC - PubMed
    1. Bousse A, Pedemonte S, Thomas BA, Erlandsson K, Ourselin S, Arridge S, Hutton BF. Markov random field and Gaussian mixture for segmented MRI-based partial volume correction in PET. Phys Med Biol. 2012;57:6681–6705. - PubMed

Publication types